Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants 2nd Edition Rosen

Test Monetary establishment For Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants 2nd Edition Rosen

1. ISBN-10

   0323554954
2. ISBN-13

   978-0323554954
3. Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 2nd Editionbuilds on the an identical foundation of clearly outlined, up-to-date, and clinically current content material materials as a result of the trusted Lehne undergraduate textual content material, whereas specializing within the data that superior apply nurses and Physician Assistants notably need for safe and environment friendly prescribing. Three introductory chapters current foundational content material materials for new prescribers inside the areas of prescriptive authority, rational drug alternative, prescription writing, and promoting optimistic outcomes of drug treatment. Core drug chapters are centered on the medication that prescribers will largely see in scientific apply. A sharp focus will be positioned on pharmacotherapeutic decision-making, with Black Discipline Warnings and new bulleted Key Prescribing Considerations choices. The second model choices totally new chapters on Genetic and Genomic Considerations, Muscarinic Antagonists and Immunomodulators, and updated content material materials all via. It’s the whole thing superior apply nursing and Physician Assistant school college students should be safe and environment friendly prescribers!
   • Introductory chapters tailored to the actual needs of prescribers cowl issues corresponding to prescriptive authority, rational drug alternative and prescription writing, and promoting optimistic outcomes of drug treatment.
   • Fastidiously centered pharmacotherapeutic content material materials shows the medication largely seen and utilized by prescribers, with emphasis not on the first drug discovered or developed in each class nonetheless on the brokers most often used at current. Predominant care medication are addressed first in each chapter as acceptable, adopted by acute care medication.
   • UNIQUE! Prescriber-focused pedagogical aids further reinforce a really highly effective information for prescribers.
   • Constructed-in safety of Canadian commerce names appears all via the textual content material and is highlighted with a well known maple-leaf icon.
   • Constructed-in safety of interprofessional collaboration addresses the rising worldwide curiosity in interprofessional collaboration and incorporates alternate options for interprofessional collaborative apply all via.
   • NEW! Genetic and Genomic Considerations chapter addresses our rising understanding of the importance of genetics and genomics in pharmacotherapeutic administration of sickness.
   • NEW! Immunomodulators chapter covers the rising place of this contemporary treatment in most cancers remedy.
   • NEW! Elevated emphasis on the needs of prescribers consists of latest Key Prescribing Considerations notably tailored for superior apply nurses (APNs) and Physician Assistants (PAs), revised introductory sickness content material materials, and refocused illustrations.
   • NEW! Expanded delineation of acute care medication now extends to the cardiac, neurologic, hypertension, and male and female reproductive chapters.
   • NEW! Significantly revised content material materials on laboratory drug monitoring has been refocused on the needs of APNs and PAs
   • NEW! Updated content material materials on drug legal guidelines, opioid dependancy, and legalized marijuana addresses these key areas of change for prescribers.
   • NEW! Illustrations, tables, and bins have been substituted for textual content material to give attention to remedy pointers (along with decision-making algorithms) and drug mechanisms of movement.
   • NEW! Improved legibility consists of the elimination of “small type” and a further user-friendly graphic design.
   • NEW! Updated content material materials covers the areas of drug legal guidelines, opioid dependancy, marijuana.